These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9137822)

  • 1. Effect of cyclins and Cdks on the cyclin B1 promoter activation.
    Moro A; Zerfass K; Joswig S; Jansen-Duerr P
    Biochem Mol Biol Int; 1997 Apr; 41(5):919-24. PubMed ID: 9137822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.
    Katula KS; Wright KL; Paul H; Surman DR; Nuckolls FJ; Smith JW; Ting JP; Yates J; Cogswell JP
    Cell Growth Differ; 1997 Jul; 8(7):811-20. PubMed ID: 9218875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
    Bitter GA
    Mol Gen Genet; 1998 Oct; 260(1):120-30. PubMed ID: 9829836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
    Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
    J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human cyclin-dependent kinases in vitro.
    Desai D; Gu Y; Morgan DO
    Mol Biol Cell; 1992 May; 3(5):571-82. PubMed ID: 1535244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation.
    Furukawa Y; Kikuchi J; Nakamura M; Iwase S; Yamada H; Matsuda M
    Br J Haematol; 2000 Sep; 110(3):663-73. PubMed ID: 10997979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
    Carstens CP; Krämer A; Fahl WE
    Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2.
    Akli S; Zhan S; Abdellatif M; Schneider MD
    Circ Res; 1999 Aug; 85(4):319-28. PubMed ID: 10455060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases.
    Meikrantz W; Schlegel R
    J Biol Chem; 1996 Apr; 271(17):10205-9. PubMed ID: 8626584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential association of p21Cip1 and p27Kip1 with cyclin E-CDK2 during rat liver regeneration.
    Pujol MJ; Jaime M; Serratosa J; Jaumot M; Agell N; Bachs O
    J Hepatol; 2000 Aug; 33(2):266-74. PubMed ID: 10952244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells.
    Lewis JS; Thomas TJ; Klinge CM; Gallo MA; Thomas T
    J Mol Endocrinol; 2001 Dec; 27(3):293-307. PubMed ID: 11719282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.
    Perkins ND; Felzien LK; Betts JC; Leung K; Beach DH; Nabel GJ
    Science; 1997 Jan; 275(5299):523-7. PubMed ID: 8999795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.